Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Classement en actions #18297
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Prix de l'action
$5.59
Dernière synchronisation: 2026-09-02
Capitalisation boursière
$205.21M
Changement (1 jour)
6.27%
Changement (1 an)
86.33%
Pays
US
Échange Armata Pharmaceuticals, Inc. (ARMP)

Catégorie

Historique du rendement du dividende pour Armata Pharmaceuticals, Inc. (ARMP)
Le rendement du dividende (TTM) de Armata Pharmaceuticals, Inc. (symbole boursier : ARMP) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Armata Pharmaceuticals, Inc. (ARMP) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
0.00%
US
2.48%
AU
0.00%
CH